Brief: Synthaverse Signs Annex to Extend CoraPharm Cooperation Deal Into New Markets

Synthaverse SA

28/07/2026 08:55

July 28 (Reuters) - Synthaverse SVEP.WA:
SIGNS ANNEX TO SEPT 5 2023 COOPERATION DEAL WITH CORAPHARM CONCERNING REGISTRATION AND DISTRIBUTION OF ONKO BCG
ANNEX TO EXPAND DEAL INTO FIVE MARKETS FROM TWO, ADDING ALBANIA, NORTH MACEDONIA AND MONTENEGRO 
SAYS VALUE UNDER 5 YEAR SALES PLAN TO NEW MARKETS ESTIMATED AT EUR 2.76 MLN
        
 Source text https://tinyurl.com/3skhv2fv
 Further company coverage: SVEP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))